National Drug Code (NDC) Database
-
NDC:
64566-0016
-
Nonproprietary Name:
Isotretinoin
-
Dosage Form:
CAPSULE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
30 mg/1
-
Substance:
ISOTRETINOIN
-
Start Marketing Date:
2024-09-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Catalent Ontario Limited
-
NDC:
61474-4411
-
Nonproprietary Name:
Doxylamine Succinate
-
Dosage Form:
CAPSULE, LIQUID FILLED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
6.25 mg/1
-
Substance:
DOXYLAMINE SUCCINATE
-
Start Marketing Date:
2026-03-31
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Catalent Pharma Solution, LLC
-
NDC:
11014-0471
-
Nonproprietary Name:
Tivozanib
-
Dosage Form:
CAPSULE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
1.35 mg/1
-
Substance:
TIVOZANIB HYDROCHLORIDE
-
Start Marketing Date:
2017-08-24
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Catalent Pharma Solutions LLC
-
NDC:
11014-0707
-
Nonproprietary Name:
estradiol
-
Dosage Form:
INSERT
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
10 ug/1
-
Substance:
ESTRADIOL
-
Start Marketing Date:
2024-06-20
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
CATALENT U.K. SWINDON ZYDIS LIMITED
-
NDC:
62938-0044
-
Nonproprietary Name:
Fingolimod Lauryl Sulfate
-
Dosage Form:
TABLET, ORALLY DISINTEGRATING
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
0.5 mg/1
-
Substance:
FINGOLIMOD LAURYL SULFATE
-
Start Marketing Date:
2023-02-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Catalent UK Swindon Zydis Limited
-
NDC:
62938-0046
-
Nonproprietary Name:
Rizatriptan
-
Dosage Form:
TABLET, ORALLY DISINTEGRATING
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
10 mg/1
-
Substance:
RIZATRIPTAN BENZOATE
-
Start Marketing Date:
2019-06-22
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Cayman Pharma s r.o.
-
NDC:
61556-030
-
Nonproprietary Name:
Epoprostenol sodium
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
EPOPROSTENOL SODIUM
-
Start Marketing Date:
2011-04-06
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Cayman Pharma s.r.o.
-
NDC:
61556-090
-
Nonproprietary Name:
Latanoprostene Bunod
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
LATANOPROSTENE BUNOD
-
Start Marketing Date:
2022-09-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Ce Acquisition Co LLC
-
NDC:
83271-0005
-
Nonproprietary Name:
Ethanol
-
Dosage Form:
LIQUID
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
95 L/100L
-
Substance:
ALCOHOL
-
Start Marketing Date:
2025-06-06
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
65326-004
-
Nonproprietary Name:
Latanoprost
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
LATANOPROST
-
Start Marketing Date:
2004-08-30
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Create a New Buying Request
Fields marked with * are mandatory.